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Background. End Stage Renal Disease (ESRD) normally requires dialysis or transplantation for survival. Since ESRD patients are
on long term dialysis, infections such as Hepatitis B (HBV) and Hepatitis C (HCV) are commonly reported. Methods. This was a
retrospective study carried out at a government hospital during a 12-month period from January 2013 to December 2013. The data
was collected using a predesigned pro forma to note the etiology, gender, age, and HBsAg and anti-HCV test result of each patient.
Results. 444 children suffering from ESRD were included in our analysis. The mean age of sample was 12.7 ± 4.1 years. Sixty percent
(𝑛 = 262) of the children were boys. The most common etiology of ESRD was kidney stones (𝑛 = 44, 29.3%). HBV was positive
in 11 children (2.5%) while HCV was positive in 13 (2.9%). Conclusion. This study asserts the need for carrying out further work
to confirm these findings and expand our recommendations. It is imperative to reliably determine the burden of HBV and HCV
disease and to determine the aetiology of their spread especially in children with ESRD.

1. Introduction
End Stage Renal Disease (ESRD), the stage 5 of chronic
kidney disease, normally requires dialysis or transplantation
for survival. The burden of ESRD in children is lesser as
compared with adults; however, if ESRD occurs in children,
consequences can be catastrophic. It should be pointed out
that children on dialysis have 30 to 150 times higher mortality
rates compared with the general children population [1].
Children with ESRD end up dying from variety of causes
such as cardiovascular diseases, life threatening infections,
and malignancy [2].
Since ESRD patients are on long term dialysis, infections
such as Hepatitis B (HBV) and Hepatitis C (HCV) are commonly reported. HBV is a major cause of mortality in such
patients [3]. Although vaccination has significantly reduced
mortality rates, dialysis can shorten the duration of immunity
against HBV by lowering the protective antibody levels in
children who were vaccinated as infants [3, 4]. Moreover,
the duration of dialysis has high predictive risk for HCV
infections. This was consistent with a study in which all
patients who were anti-HCV positive had been on dialysis for

a mean of 105 months [5]. Furthermore, a study also reported
a steady rise of the HCV antibody titres in children during
the period of dialysis treatment [6]. This may be due to the
number of blood transfusions at the time of haemodialysis
which has been shown to be a significant risk of HCV
infection [7].
Many studies have been conducted to determine the rate
of HBV and HCV infections among the paediatric ESRD
population. For instance a study conducted in Saudi Arabia
showed that the prevalence of anti-HCV in children with
ESRD was 45% compared with the prevalence of 1% among
the controls [3]. Similarly, another study showed that the
prevalence (11.2%) of anti-HCV was much higher in children
with chronic renal disease. A study conducted back in 1985
on patients aged between 2 and 18 years with chronic renal
failure showed a seroprevalence of 66.7% for HBsAg [8].
Not much data is available on this subject from our part of
the world due to nonexistence of a centralized registry. While
the incidence of ESRD in the United States is declining (a
5.8% decrease in 2012), it continues to be rising in Pakistan,
with an estimated annual incidence of >100 new cases per
million population [9, 10]. Epidemiological data on HBV and
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HCV infection is therefore important for strategies to tackle
the spread of the disease. Moreover, it is imperative to reliably
determine the burden of HBV and HCV disease, to determine
the etiology of spread especially in children with ESRD, to
identify any areas with higher endemicity than the rest of
the country and to understand the risk factors associated
with its transmission. The primary objective of our study was
to determine the frequency rate of HBsAg and anti-HCV
among children with ESRD while the secondary objective was
to determine the etiology, gender, and age groups that are
predominantly infected.

2. Methods
This was a retrospective study carried out at a government
hospital during a 12-month period from January 2013 to
December 2013. All subjects’ information was kept confidential and a written informed consent was obtained from each
participant. All ethical responsibilities were met in accordance with Helmshki law. Since our government hospital is
located in the center of the city where people come from all
over the city, a good representative sample of the entire city
was collected and analyzed.
The sample population included all those children under
the age of 18 years who were documented cases of ESRD.
ESRD was defined as individuals with a glomerular filtration
rate (GFR) of <15 mL/min/1.73 m2 or with signs and symptoms of kidney failure. The latter included patients who were
currently on dialysis or patients who underwent transplantation.
Blood samples were collected. HBsAg and anti-HCV
were tested by in vitro immunochromatographic one step
assay designed for qualitative determination. The data was
collected using a predesigned pro forma to note the aetiology,
gender, age, and HBsAg and anti-HCV test result of each
subject. Data was collected by three investigators who were
also coauthors of the study. After explaining the purpose
of the study, each participant was asked to fill the consent
form. Two independent authors queried the data from the
database to ensure no error was made. The results were cross
verified among the 2 authors to ensure integrity of data. Any
discrepancy was solved through mutual consensus.
2.1. Statistical Analysis. IBM SPSS v. 21 (SPSS Inc., Illinois,
US) was used to analyze the data. Mean ± standard deviation
was computed to describe continuous variable. Age was
classified into 3 categories, namely, 1–9 years, 10–14 years, and
15–18 years. Frequencies and percentages were calculated for
presenting categorical variables such as demographic profile
and clinical status of patients. Age based stratified analysis
was also performed to observe pattern of clinical profile
among ESRD children.

3. Results
Our sample population consisted of 444 children suffering
from ESRD. The mean age of children was 12.7 ± 4.1 years.
20% (𝑛 = 91) of the children were less than 10 years of age
while 39% (𝑛 = 174) were in the age group 15–18 (Table 1).
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Table 1: Demographic profile of ESRD children.
Frequency

Percentage

0
91
179
174

0%
20.5%
40.3%
39.2%

262
182

59.0%
41.0%

216
53
9
24
137
5

48.6%
11.9%
2.0%
5.4%
30.9%
1.1%

Age groups (years)
<1
1–9
10–14
15–18
Gender
Male
Female
Province
Sindh
Punjab
KPK
Baluchistan
Karachi
Others

Table 2: Clinical status of ESRD children.

Aetiology
Unknown
Stone
Nephrotic
Glomerulonephritis (nephritic)
Obstructive uropathy
SSK (small shrunken kidneys)
Others (Wilms, BOO,
gastroenteritis, etc.)
VUR (vesicoureteral reflux)
Hepatitis B
Positive
Negative
Hepatitis C
Positive
Negative

Frequency

Percentage

294
44
22
22
9
28

66.2%
9.9%
5.0%
5.0%
2.0%
6.3%

22

5.0%

3

.7%

11
433

2.5%
97.5%

13
431

2.9%
97.1%

60% (𝑛 = 262) of the children were boys. The reason for ESRD
was known for 33.8% (𝑛 = 150) patients only (Figure 1). The
most common known aetiology of ESRD was kidney stones
(𝑛 = 44, 29.3%), followed by small shrunken kidneys (𝑛 = 28,
19%) (Table 2).
HBV was positive in 11 children (2.5%) while HCV
was positive in 13 (2.9%) (Table 2). The proportion of HBV
positivity was found to be 1.1% (𝑛 = 1) among children less
than 10 years. This proportion was higher in children with
the age groups 10–14 and 15–18 years with 2.8% (𝑛 = 5) and
2.9% (𝑛 = 5), respectively. On the other hand, HCV was
positive in 2.2% (𝑛 = 2), 1.7% (𝑛 = 3), and 4.6% (𝑛 = 8)
of the children aged 1–9 years, 10–14 years, and 15–18 years,
respectively (Table 3).
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GN (nephritic)
15%

Obstructive
uropathy
6%

SSK
Nephrotic
15%

Known
34%

Unknown
66%

19%
Other
15%

Stone
29%

VUR
2%

Figure 1: Percentage distribution of Aetiology of ESRD among children.
Table 3: Stratified analysis of clinical status among children with ESRD.

1–9
Aetiology
Unknown
Stone
Nephrotic
GN (nephritic)
Obstructive uropathy
SSK
Others (Wilms, BOO, gastroenteritis, etc.)
VUR
Hepatitis B
Positive
Negative
Hepatitis C
Positive
Negative

Age groups (years)
10–14
Frequency
Percentage

Percentage

61
10
4
5
1
5
4
1

67.0%
11.0%
4.4%
5.5%
1.1%
5.5%
4.4%
1.1%

116
16
10
7
6
15
8
1

64.8%
8.9%
5.6%
3.9%
3.4%
8.4%
4.5%
0.6%

117
18
8
10
2
8
10
1

67.2%
10.3%
4.6%
5.7%
1.1%
4.6%
5.7%
0.6%

1
90

1.1%
98.9%

5
174

2.8%
97.2%

5
169

2.9%
97.1%

2
89

2.2%
97.8%

3
176

1.7%
98.3%

8
166

4.6%
95.4%

Table 3 shows age based stratified analysis for secondary
outcome variables such as aetiology. The aetiology varied
among different age groups. Kidney stones were the most
common cause for ESRD among all stratified age groups.
Children under the age of 10 years had the highest percentage
of kidney stone being the reason for their kidney failure (𝑛 =
10, 11%) followed closely by the 15–18 years age group (𝑛 = 18,
10.3%).

4. Discussion
The prevalence of HBV and HCV in our sample population is
2.5% and 2.9%, respectively. A major hurdle in recording the
prevalence of HBV and HCV in the Pakistani population is
the lack of reporting to a national database. A study showed
that the prevalence of HCV among the general population
is 4.5% [11], while another study estimated that 17 million
people in Pakistan are affected [12] compared with the global
reported prevalence of less than 3%, 1.8% in Europe, and 2.3%

Frequency

15–19
Percentage

Frequency

in USA [13]. Prevalence of HBV has been shown to be 2.5%
in the general population [14]. A few studies carried out in
the paediatric population by Khan [15], Parker et al. [16], and
Hyder et al. [17] showed that the rates of HCV are 4.09%, 1.3%,
and 0.58%, respectively, while a newer study determined the
prevalence to be 3.3% in the age group 9–19 years [18], while
a review showed the incidence of HBV as 1.9–3.6% [19].
Keeping the route of infection in mind, some reasons for
the higher prevalence of these infections in our country can
be deduced. Majority of our population obtains their haircut
and facial shaves from unhygienic barber shops, where the
practice of using fresh blades for each individual is dubious
at best. While this dangerous act used to be much more
common, awareness regarding the hazards has reduced it to
a great extent. There still remains a lot of work to be done,
as these practices have not been completely abolished and
many people do not recognize the significance of needlestick injuries, proper disposal of used sharp objects, sharing
of toothbrushes, and unsafe blood donations, apart from
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the pervasive presence of intravenous drug abuse. It is
possible that many of the children are infected either directly
through these injuries or accidents or through vertical transmission from their mothers.
Hepatitis infections in ESRD patients, especially children, represent a special subset of the population. The
inflicted individuals have to undergo maintenance peritoneal
dialysis, haemodialysis, or renal transplantation. All these
are associated with risks of blood-borne infections being
transmitted, among other complications. Being on dialysis
means repetitive exposure to potentially infected instruments
and hence increased risk of infections. Studies from different
regions show varying trends of HBV and HCV infection in
these patients. A Senegalese study showed 5.6% prevalence of
HCV in ESRD patients [20], while in Libya it was shown to be
31.1%, in Germany 6.1%, in Saudi Arabia 50%, and in Turkey
20.2% [21]. On the other hand, the observed prevalence of
HBV infection in ESRD patients was 2.6% in Libya, 4.1%
in Europe, 2.2% in Japan, and 2.4% in USA [21]. A local
study revealed frequency of HBV as 2.1% and HCV as 16.4%
[22]. While these studies mostly state the frequencies among
the adult populations suffering from ESRD, some researchers
have worked on the paediatric ESRD patients too. From these,
the prevalence in Saudi population is 45% for HCV and 15%
for HBV [3], in Italian population 15% for HCV [7], and in
the Egyptian paediatric ESRD population 5.9% for HBV and
94.1% for HCV [23]. All these report a much higher incidence
of the investigated diseases as compared to our study. As the
risk of being infected by blood-borne viruses increases with
exposure, patients who are on dialysis for longer periods are at
higher risk than those being started on dialysis recently. This
would lead to the expectation that children with ESRD would
be less likely to be infected as compared to adults with the
same affliction since they have been enduring dialysis longer.
We further found that the aetiology of ESRD in our
population was unknown in 66.2%. Among the known
causes, the most common in our sample was urolithiasis. The
main causes of ESRD in children are quite different from
those in adults. Diabetes and hypertension being common
culprits in the latter [24]. As far as the aetiology in children
is concerned, there is a marked variety between countries
and regions. While congenital anomalies and hereditary
nephropathies are reported from developed nations, infections and other acquired causes make up the majority in
developing countries [25, 26]. The paediatric aetiology in our
population remains mostly unknown, with a high incidence
of urinary tract stones which is in contrast to that reported in
Western countries. Stone formation leading to renal failure
has a high incidence in our region [27]. A study conducted
in Karachi shows nephrolithiasis as the major factor in
16%, glomerulonephritis in 26%, and unknown in 50% [28]
compared with hereditary/congenital disorders (35.9%) and
glomerular disease (21.5%) in USA [9]. This is consistent
with our findings which show stone formation as the leading
known cause of ESRD in children.
Pakistan, among other countries of the Afro-Asian belt,
has one of the highest incidences of urolithiasis in the world.
This entity is observed both in adults and in children and
is often neglected which leads to patients presenting with
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late disease; a challenge to treat [15]. Paediatric urolithiasis
in Western countries occurs mainly on the backdrop of
metabolic abnormalities, anatomical anomalies, and infections while the preponderant etiological basis in developing
nations is not clearly defined [29]. It has been shown that
there is a genetic component involved in increasing the risk of
stone formation, and dietary and environmental components
also contribute to the metabolic abnormalities leading to this
phenomenon. Relation of physical activity and fluid intake
too is well documented [30]. The importance of urolithiasis
as a cause of ESRD is based on the fact that it is quite easily
preventable and manageable, hence reducing the burden of
patients developing renal failure.
Extrapolating on these evidences, one can make some
intelligent guesses regarding the role of environment and diet
on our results. In a subtropical region with the sun shining
almost the whole year, high temperatures, and humidity, it
is no surprise that people living in Pakistan, especially the
southern coastal areas, arid Balochistan, and lower Punjab,
tend to be dehydrated. Increased consumption of salt is
common in our society and, with a significant portion of the
population not able to afford meat, consumption of vegetables
with the resultant load of oxalate provides additional risk
factors. An increase in dietary calcium, associated with dairy
consumption, reduces the formation of oxalate stones, which
could be a possible contributory factor in those with poor
feeding habits [31]. These points can help formulating advice
to high-risk patients and the population in general regarding the potential prevention of stone formation, leading
to decreased morbidity and mortality associated with this
pathology. Prompt attention to the symptoms produced by
urolithiasis is essential to achieve a reduction in incidence;
clinicians should be careful not to dismiss symptoms of
abdominal pain, haematuria, or dysuria. Another hurdle is
neglect and delay in obtaining proper medical advice by the
patients and their families; some of this is due to silent stones,
but a more important cause is the practice among people,
especially from rural background, to consult hakims/quacks
for their ailments.
Our study has an advantage over some studies cited above
in having a much larger sample size. Since this study was
carried out at a dedicated center for kidney disease, the
volume of patients is quite high. Not many centers operate
in our country providing state-of-the-art care completely
free of cost; this means that the catchment area is quite
widespread in terms of geography and socioeconomic strata.
It is evident from the literature review that not many studies
are available regarding the epidemiology of specific diseases
in special populations. Our study focuses on a subset within
a subset, namely, children ailing with ESRD. While this sort
of targeted researches may not be of interest to the casual
investigator or practitioner, they are important for those
intimately associated with these specialties as they provide
important epidemiological data as well as guide important
decisions on how to reduce the adverse events patients
suffered from during their care.
Unarguably, our study has several limitations as well. The
foremost are the facts that this was a retrospective study
done in the year 2013; hence, any cases before or after that
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year were not accounted for. Also, the study was done at a
single center. Although the center is located at the city center
and would account for most of the cases reported, it still
remains our limitation. Our hospital is a government based
public institution. Hence, the majority of the children would
represent people from a low socioeconomic background.

5. Conclusion
Our study highlights a high prevalence of HBV and HCV
in paediatric ESRD patients. This unfortunate affliction represents an additional comorbidity for our patients who are
already fighting a life-threatening condition. There is a need
for carrying out further work to confirm these findings and
expand our recommendations, particularly the sensitive issue
regarding proper blood screening. NGOs and governmental
institutions can play a pivotal role in bringing out the true
picture as defined in earlier studies and awareness projects.
Further data regarding these infections should be collected on
a national level, and appropriate measures should be taken by
both the government and private setups to reduce the spread
of HBV and HCV as they will have a big effect on the quality of
life of patients as well as playing a role in reducing mortality.
Hence, focused efforts should be done to prevent the spread
of HBV and HCV and thereby reduce the burden of related
chronic liver disease in the country and region, as a whole,
especially in a region dominated with child population.
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